Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie Amberg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Praxis Der Kinderpsychologie Und Kinderpsychiatrie|March 27, 2025
Janin Zimmermann, Stefanie Amberg, Ulrike Lux, et al.
Current Cancer Drug Targets|June 30, 2020
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINELSven Nilsson, Alexander Stein, Christian Rolfo, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Journal of Hepatology|January 21, 2023
A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantationAndrea Schlegel, Matteo Mueller, Xavier Muller, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Praxis Der Kinderpsychologie Und Kinderpsychiatrie|March 27, 2025
Janin Zimmermann, Stefanie Amberg, Ulrike Lux, et al.
Current Cancer Drug Targets|June 30, 2020
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINELSven Nilsson, Alexander Stein, Christian Rolfo, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
Journal of Hepatology|January 21, 2023
A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantationAndrea Schlegel, Matteo Mueller, Xavier Muller, et al.
Pageof 1